Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women

Pharmacology Biochemistry and Behavior

Volumn 87, Issue 2, 2007, Pages 258-266

  Lile, Joshua A ^a   Kendall, Sherie L ^a   Babalonis, Shanna ^b   Martin, Catherine A ^a   Kelly, Thomas H ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Amphetamine; Drug Discrimination; Estrogen; Hormone; Menstrual Cycle; Subjective

Indexed keywords

DEXAMPHETAMINE; ESTRADIOL; PROGESTERONE;

ADULT; ARTICLE; BIRTH CONTROL; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; NORMAL HUMAN; ORAL CONTRACEPTION; PREMENOPAUSE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SENSITIVITY ANALYSIS; VOLUNTEER;

ADOLESCENT; ADULT; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; HEART RATE; HUMANS; PSYCHOMOTOR PERFORMANCE; SUBSTANCE-RELATED DISORDERS;

EID: 34250749074     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.04.022     Document Type: Article

References (39)

1. Angrist B., Corwin J., Bartlik B., and Cooper T. Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biol Psychiatry 22 (1987) 1357-1368
2. Balthazart J., and Ball G.F. Is brain estradiol a hormone or a neurotransmitter. Trends Neurosci 29 (2006) 241-249
3. Becker J.B. Direct effects of 17β-estradiol on striatum: sex differences in dopamine release. Synapse 5 (1990) 157-164
4. Becker J.B., and Ramirez V.D. Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro. Brain Res 204 (1981) 361-372
5. Caine S.B., Bowen C.A., Yu G., Zuzga D., Negus S.S., and Mello N.K. Effect of gonadectomy and gonadal hormone replacement on cocaine self-administration in female and male rats. Neuropsychopharmacology 29 (2004) 929-942
6. Carroll M.E., Lynch W.J., Roth M.E., Morgan A.D., and Cosgrove K.P. Sex and estrogen influence drug abuse. Trends Pharmacol Sci 25 (2004) 273-279
7. Chait L.D., Uhlenhuth E.H., and Johanson C.E. The discriminative stimulus and subjective effects of d-amphetamine in humans. Psychopharmacology 86 (1985) 307-312
8. Evans S.M., and Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women but not in men. Neuropsychopharmacology 31 (2006) 659-674
9. Evans S.M., Haney M., and Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 159 (2002) 397-406
10. Heishman S.J., and Henningfield J.E. Discriminative stimulus effects of d-amphetamine methylphenidate and diazepam in humans. Psychopharmacology 103 (1991) 436-442
11. Holtzman S.G., and Locke K.W. Neural mechanisms of drug stimuli: experimental approaches. Psychopharmacol Ser 4 (1988) 138-153
12. Hu M., Crombag H.S., Robinson T.E., and Becker J.B. Biological basis of sex differences in the propensity to self-administer cocaine. Neuropsychopharmacology 29 (2004) 81-85
13. Jackson L.R., Robinson T.E., and Becker J.B. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology 31 (2006) 129-138
14. Justice A.J.H., and de Wit H. Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 145 (1999) 67-75
15. Justice A.J.H., and de Wit H. Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav 66 (2000) 509-515
16. Justice A.J.H., and de Wit H. Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology 71 (2000) 51-59
17. Kelly T.H., Foltin R.W., Emurian C.S., and Fischman M.W. Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine alcohol and diazepam. J Anal Toxicol 17 (1993) 264-272
18. Kelly T.H., Stoops W.W., Perry A.S., Prendergast M.A., and Rush C.R. Clinical neuropharmacology of drugs of abuse: a comparison of drug discrimination and self-report measures. Behav Cogn Neurosci Rev 2 (2003) 227-260
19. Kelly T.H., Robbins G., Martin C.A., Fillmore M., Lane S.D., Harrington N.G., et al. Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology 189 (2006) 17-25
20. Lile J.A., Stoops W.W., Vansickel A.R., Glaser P.E., Hays L.R., and Rush C.R. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of d-amphetamine in humans. Neuropsychopharmacology 30 (2005) 2103-2114
21. Lile J.A., Stoops W.W., Wagner F.P., Glaser P.E., and Rush C.R. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. Neuropsychopharmacology 30 (2005) 2103-2114
22. Lukas S.E., Sholar M., Lundahl L.H., Lamas X., Kouri E., Wines J.D., et al. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology 125 (1996) 346-354
23. Lynch W.J., Roth M.E., and Carroll M.E. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 164 (2002) 121-137
24. Martin W.R., Sloan J.W., Sapira J.D., and Jasinski D.R. Physiologic subjective and behavioral effects of amphetamine methamphetamine ephedrine phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12 (1971) 245-258
25. McLeod D.R., Griffiths R.R., Bigelow G.E., and Yingling J.E. An automated version of the digit symbol substitution test (DSST). Behav Res Meth Instrum 14 (1982) 463-466
26. Mendelson J.H., Mello N.K., Sholar M.B., Siegel A.J., Kaufman M.J., Levin J.M., et al. Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology 21 (1999) 294-303
27. Oliveto A.H., Bickel W.K., Hughes J.R., Shea P.J., Higgins S.T., and Fenwick J.W. Caffeine drug discrimination in humans: acquisition specificity and correlation with self-reports. J Pharmacol Exp Ther 261 (1992) 885-894
28. Preston K.L., and Bigelow G.E. Subjective and discriminative effects of drugs. Behav Pharmacol 2 (1991) 293-313
29. Price T.M., Blauer K.L., Hansen M., Stanczyk F., Lobo R., and Bates G.W. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17β-estradiol. Obstet Gynaecol 89 (1997) 340-345
30. Rush C.R., Kollins S.H., and Pazzaglia P.J. Discriminative-stimulus and participant-rated effects of methylphenidate bupropion and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol 6 (1998) 32-44
31. Rush C.R., Stoops W.W., Hays L.R., and Glaser P.E.A. Alprazolam attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Clin Psychopharmacol 24 (2004) 410-420
32. Rush C.R., Stoops W.W., Hays L.R., Glaser P.E.A., and Hays L.S. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther 306 (2003) 195-204
33. Sofuoglu M., Dudish-Poulsen S., Nelson D., Pentel P.R., and Hatsukami D.K. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp Clin Psychopharmacol 7 (1999) 274-283
34. Sofuoglu M., Mitchell E., and Kosten T.R. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol Biochem Behav 78 (2004) 699-705
35. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2004 National Survey on Drug Use and Health: National findings (2005), Office of Applied Studies Publications and Data Dissemination, Rockville, MD
36. Thorneycroft I.H., Mishell Jr. D.R., Stone S.C., Kharma K.M., and Nakamura R.M. The relation of serum 17-hydroxyprogesterone and estradiol-17β levels during the human menstrual cycle. Am J Obstet Gynecol 111 (1971) 947-951
37. van Etten M.L., Neumark Y.D., and Anthony J.C. Male-female differences in the earliest stages of drug involvement. Addiction 94 (1999) 1413-1419
38. White T.L., Justice A.J.H., and de Wit H. Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73 (2002) 729-741
39. Zhou W., Cunningham K.A., and Thomas M.L. Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Mol Brain Res 100 (2002) 75-83